Treatment with intravenous bisphosphonates - drugs used to reduce harm done to bones by cancer or cancer therapy - increases the risk of jaw or facial bone disease or infection, a large-scale comparative study by researchers at the University of Texas Medical Branch at Galveston (UTMB) has found. [click link for full article]